Etoposide targets 2A protease to inhibit enterovirus 71 replication

ABSTRACT Enterovirus 71 (EV71) is a major pathogen that causes hand, foot, and mouth disease (HFMD) in infants and children. Notably, no clinically approved drugs specifically target EV71. The EV71 2A protease (2Apro), a cysteine protease produced by the virus, is essential for the virus’ replicatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Qinqin Liang, Sai Shi, Qingjie Zhang, Yaxin Wang, Sheng Ye, Binghong Xu
Format: Article
Language:English
Published: American Society for Microbiology 2025-01-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02200-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850077506524151808
author Qinqin Liang
Sai Shi
Qingjie Zhang
Yaxin Wang
Sheng Ye
Binghong Xu
author_facet Qinqin Liang
Sai Shi
Qingjie Zhang
Yaxin Wang
Sheng Ye
Binghong Xu
author_sort Qinqin Liang
collection DOAJ
description ABSTRACT Enterovirus 71 (EV71) is a major pathogen that causes hand, foot, and mouth disease (HFMD) in infants and children. Notably, no clinically approved drugs specifically target EV71. The EV71 2A protease (2Apro), a cysteine protease produced by the virus, is essential for the virus’ replication and has a significant impact on the functioning of host cells. Thus, it presents a valuable target for the discovery of antiviral medications. In this study, based on the monomers and their derivatives in the Library of Traditional Chinese Medicine (TCM), we performed virtual screening and biological experiments. We identified a derivative of a traditional herbal monomer, Etoposide, commonly isolated from the roots and rhizomes of Podophyllum spp. Etoposide inhibited replication of EV71 A, B, C, and CVA16 viruses in a concentration-dependent manner in a variety of cell lines with minimal cytotoxicity. Furthermore, both molecular dynamics simulations and site-directed mutagenesis assays revealed that Etoposide inhibited the activity of the EV71 2A protease by mainly binding to two residues, Y89 and P107. The findings indicate that Etoposide serves as a promising inhibitor of the EV71 2Apro, demonstrating strong antiviral properties and positioning itself as a formidable candidate for clinical trials against EV71.IMPORTANCEWe first used a drug screening approach focused on monomeric compounds and their derivatives from traditional Chinese medicine to identify an EV71 2Apro inhibitor—Etoposide. We then performed biological experiments to validate that Etoposide suppresses the replication of the EV71 virus in a concentration-dependent manner with minimal cytotoxicity to various cell lines. Remarkably, it shows inhibitory activity against EV71 A, B, C, and CVA16, suggesting that Etoposide may be a potential broad-spectrum inhibitor. We revealed a novel mechanism that Etoposide inhibits EV71 proliferation by targeting 2Apro, and the interactions with Y89 and P107 are of great importance. The findings suggest that Etoposide serves as a promising inhibitor of EV71 2Apro, demonstrating significant antiviral properties. It stands out as a strong candidate for broad-spectrum applications in clinical research.
format Article
id doaj-art-7522db9b5204436cb2947d924faddb32
institution DOAJ
issn 2165-0497
language English
publishDate 2025-01-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj-art-7522db9b5204436cb2947d924faddb322025-08-20T02:45:46ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972025-01-0113110.1128/spectrum.02200-24Etoposide targets 2A protease to inhibit enterovirus 71 replicationQinqin Liang0Sai Shi1Qingjie Zhang2Yaxin Wang3Sheng Ye4Binghong Xu5Frontiers Science Center for Synthetic Biology (Ministry of Education), Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, ChinaDepartment of Medical and Pharmaceutical Informatics, Hebei Medical University, Shijiazhuang, ChinaFrontiers Science Center for Synthetic Biology (Ministry of Education), Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, ChinaFrontiers Science Center for Synthetic Biology (Ministry of Education), Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, ChinaFrontiers Science Center for Synthetic Biology (Ministry of Education), Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, ChinaFrontiers Science Center for Synthetic Biology (Ministry of Education), Haihe Laboratory of Sustainable Chemical Transformations, Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin, ChinaABSTRACT Enterovirus 71 (EV71) is a major pathogen that causes hand, foot, and mouth disease (HFMD) in infants and children. Notably, no clinically approved drugs specifically target EV71. The EV71 2A protease (2Apro), a cysteine protease produced by the virus, is essential for the virus’ replication and has a significant impact on the functioning of host cells. Thus, it presents a valuable target for the discovery of antiviral medications. In this study, based on the monomers and their derivatives in the Library of Traditional Chinese Medicine (TCM), we performed virtual screening and biological experiments. We identified a derivative of a traditional herbal monomer, Etoposide, commonly isolated from the roots and rhizomes of Podophyllum spp. Etoposide inhibited replication of EV71 A, B, C, and CVA16 viruses in a concentration-dependent manner in a variety of cell lines with minimal cytotoxicity. Furthermore, both molecular dynamics simulations and site-directed mutagenesis assays revealed that Etoposide inhibited the activity of the EV71 2A protease by mainly binding to two residues, Y89 and P107. The findings indicate that Etoposide serves as a promising inhibitor of the EV71 2Apro, demonstrating strong antiviral properties and positioning itself as a formidable candidate for clinical trials against EV71.IMPORTANCEWe first used a drug screening approach focused on monomeric compounds and their derivatives from traditional Chinese medicine to identify an EV71 2Apro inhibitor—Etoposide. We then performed biological experiments to validate that Etoposide suppresses the replication of the EV71 virus in a concentration-dependent manner with minimal cytotoxicity to various cell lines. Remarkably, it shows inhibitory activity against EV71 A, B, C, and CVA16, suggesting that Etoposide may be a potential broad-spectrum inhibitor. We revealed a novel mechanism that Etoposide inhibits EV71 proliferation by targeting 2Apro, and the interactions with Y89 and P107 are of great importance. The findings suggest that Etoposide serves as a promising inhibitor of EV71 2Apro, demonstrating significant antiviral properties. It stands out as a strong candidate for broad-spectrum applications in clinical research.https://journals.asm.org/doi/10.1128/spectrum.02200-24HFMDEV71antiviralEtoposideinhibitor
spellingShingle Qinqin Liang
Sai Shi
Qingjie Zhang
Yaxin Wang
Sheng Ye
Binghong Xu
Etoposide targets 2A protease to inhibit enterovirus 71 replication
Microbiology Spectrum
HFMD
EV71
antiviral
Etoposide
inhibitor
title Etoposide targets 2A protease to inhibit enterovirus 71 replication
title_full Etoposide targets 2A protease to inhibit enterovirus 71 replication
title_fullStr Etoposide targets 2A protease to inhibit enterovirus 71 replication
title_full_unstemmed Etoposide targets 2A protease to inhibit enterovirus 71 replication
title_short Etoposide targets 2A protease to inhibit enterovirus 71 replication
title_sort etoposide targets 2a protease to inhibit enterovirus 71 replication
topic HFMD
EV71
antiviral
Etoposide
inhibitor
url https://journals.asm.org/doi/10.1128/spectrum.02200-24
work_keys_str_mv AT qinqinliang etoposidetargets2aproteasetoinhibitenterovirus71replication
AT saishi etoposidetargets2aproteasetoinhibitenterovirus71replication
AT qingjiezhang etoposidetargets2aproteasetoinhibitenterovirus71replication
AT yaxinwang etoposidetargets2aproteasetoinhibitenterovirus71replication
AT shengye etoposidetargets2aproteasetoinhibitenterovirus71replication
AT binghongxu etoposidetargets2aproteasetoinhibitenterovirus71replication